Annexin VIII inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of Annexin VIII, a member of the annexin family of calcium-dependent phospholipid-binding proteins. Annexin VIII is involved in various cellular processes, including membrane trafficking, signal transduction, and the regulation of cytoskeletal dynamics. The annexin family is characterized by their ability to bind to phospholipids in the presence of calcium ions, which facilitates their interaction with cellular membranes and their involvement in membrane-related events such as vesicle formation, membrane repair, and cell surface dynamics. Annexin VIII, in particular, is believed to play a role in the regulation of membrane organization and the modulation of membrane-associated signaling pathways, contributing to processes such as cell migration, endocytosis, and exocytosis. By inhibiting Annexin VIII, researchers can disrupt these membrane-related functions, offering a tool to study the specific contributions of Annexin VIII to cellular organization and function.
In research, Annexin VIII inhibitors are valuable for exploring the molecular mechanisms by which Annexin VIII influences cellular membrane dynamics and the broader implications of these processes on cellular behavior. By blocking Annexin VIII activity, scientists can investigate how the inhibition affects membrane-associated processes such as vesicle trafficking, membrane fusion, and the organization of membrane domains. This inhibition allows researchers to study the downstream effects on cellular functions that depend on precise membrane organization, including cell migration, intracellular signaling, and the response to extracellular stimuli. Additionally, Annexin VIII inhibitors provide insights into the interactions between Annexin VIII and other proteins involved in membrane dynamics, shedding light on the complex networks that regulate membrane structure and function. Through these studies, the use of Annexin VIII inhibitors enhances our understanding of the critical role of annexins in cellular physiology, the regulation of membrane-related processes, and the broader implications of membrane dynamics on cellular health and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
A modulator of calcium signaling, this chemical disrupts intracellular calcium release, which could hinder Annexin VI's calcium-dependent binding to membranes and subsequent cellular functions. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
An inhibitor of actin polymerization, it prevents the formation of actin filaments, potentially impeding Annexin VI-mediated linkage to the actin cytoskeleton and altering vesicle transport. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
A cell-permeant calcium chelator that sequesters intracellular calcium, potentially affecting Annexin VI's ability to mediate calcium-dependent interactions within the cell. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $180.00 $299.00 | 59 | |
Stabilizes actin filaments and can inhibit actin dynamics; this may alter Annexin VI-associated membrane-cytoskeleton interactions, affecting vesicle trafficking. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $89.00 $262.00 | 13 | |
An inhibitor of myosin light chain kinase (MLCK) that can affect actin-myosin contractility, indirectly modulating Annexin VI's interaction with the actin cytoskeleton. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $163.00 $300.00 $1642.00 | 18 | |
A calmodulin antagonist that may impede Annexin VI's interaction with calmodulin-dependent targets, indirectly modulating its role in membrane organization. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
A calcium channel blocker that could indirectly decrease Annexin VI's calcium-dependent activities by limiting calcium influx into cells. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $215.00 $622.00 | 5 | |
An inhibitor of Ras farnesyltransferase; while mainly affecting Ras signaling, it could indirectly modify Annexin VI's function in cell signaling and vesicle transport. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor that affects actin organization and cell motility, potentially impacting Annexin VI's interaction with the cytoskeleton and plasma membrane. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
A selective inhibitor of CaM kinase II that might indirectly affect Annexin VI's role in the regulation of calcium signaling and membrane-cytoskeleton interactions. | ||||||